Interestingly only secretion of the placental growth factor (PlGF) was increased on treatment by evofosfamide under hypoxia and only by the evofosfamide-responsive and not by the evofosfamide-resistant carcinoma cells. The gene discussed is PGF; the disease is carcinoma.